SCHEMBL18044653

SCHEMBL18044653

CN1CCC(n2cc(-c3ccc(NC(=O)c4cc5c(n(-c6ccccc6)c4=O)CCCC5=O)cc3)c3c(N)ncnc32)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TYRO3 Q06418 4/20 0.57
▸ MERTK Q12866 7/20 0.55
▸ AXL P30530 6/20 0.55
▸ RET P07949 3/20 0.49
▸ FLT3 P36888 2/20 0.48
▸ ABL1 P00519 3/20 0.47
▸ EGFR P00533 3/20 0.47
▸ SRC P12931 3/20 0.47
▸ ABL2 P42684 2/20 0.47
▸ USP2 O75604 2/20 0.47
▸ HSD17B10 Q99714 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ PKM P14618 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ TSHR P16473 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18044659 0.93 AXL (0.60) TYRO3MERTKAXLFLT3
SCHEMBL18044548 0.89 TYRO3 (0.53) TYRO3MERTKAXLRETFLT3
SCHEMBL16709454 0.89 TYRO3 (0.57) TYRO3MERTKAXLUSP2HSD17B10
SCHEMBL18044583 0.87 TYRO3 (0.55) TYRO3MERTKAXLUSP2HSD17B10
SCHEMBL18044681 0.85 TYRO3 (0.49) TYRO3MERTKAXLRETFLT3
SCHEMBL18044684 0.85 TYRO3 (0.49) TYRO3MERTKAXLRETFLT3
SCHEMBL18044641 0.84 AXL (0.55) TYRO3MERTKAXLFLT3USP2
SCHEMBL16709400 0.83 MERTK (0.53) TYRO3MERTKAXLFLT3USP2
SCHEMBL18045153 0.83 AXL (0.60) TYRO3MERTKAXLRETFLT3
SCHEMBL18044553 0.82 FLT3 (0.48) TYRO3MERTKAXLRETFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3067356-B1 PYRROLO PYRIMIDINE DERIVATIVE ONO PHARMACEUTICAL CO (JP) 2018-07-04 — — EP disclosed
US-9586967-B2 Pyrrolo pyrimidine derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2017-03-07 — — US disclosed
US-20160264579-A1 PYRROLO PYRIMIDINE DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2016-09-15 — — US disclosed
EP-3067356-A1 PYRROLO PYRIMIDINE DERIVATIVE ONO Pharmaceutical Co., Ltd. (JP) 2016-09-14 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160264579-A1 PYRROLO PYRIMIDINE DERIVATIVE AXL, FLT3, TYRO3 TYRO3 3/4885MERTK 5/4885AXL 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback